Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam E Snook

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Immunotherapy|October 24, 2014
Could targeting T-helper cells aid the development of effective cancer vaccines?Adam E Snook
Future Medicinal Chemistry|June 30, 2020
Companion vaccines for CAR T-cell therapy: applying basic immunology to enhance therapeutic efficacyAdam E Snook
Human Vaccines & Immunotherapeutics|October 31, 2017
Immunotherapy regimens for metastatic colorectal carcinomasBabar Bashir, Adam E Snook
Bioforum Europe : Trends and Techniques in Life Science Research|February 9, 2016
CANCER MUCOSA ANTIGENS A NOVEL PARADIGM IN CANCER IMMUNOTHERAPEUTICSAdam E Snook, Scott A Waldman
Discovery Medicine|November 27, 2014
Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancerMichael S Magee, Adam E Snook
Discovery Medicine|March 2, 2013
Advances in cancer immunotherapyAdam E Snook, Scott A Waldman
Personalized Medicine|May 17, 2018
The swinging pendulum of cancer immunotherapy personalizationTara S Abraham, Adam E Snook
Expert Review of Clinical Pharmacology|February 20, 2026
Could GUCY2C-targeted pharmacotherapy be effective in treating colorectal cancer?Scott A Waldman, Adam E Snook
Vaccines|November 27, 2021
Cancer Vaccines and Immunotherapy for Tumor Prevention and TreatmentJagmohan Singh, Wilbur B Bowne, Adam E Snook
Immunotherapy|June 13, 2022
Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB and PD-L1Daniel S Lefler, Adam E Snook, Babar Bashir
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Immunotherapy|October 24, 2014
Could targeting T-helper cells aid the development of effective cancer vaccines?Adam E Snook
Future Medicinal Chemistry|June 30, 2020
Companion vaccines for CAR T-cell therapy: applying basic immunology to enhance therapeutic efficacyAdam E Snook
Human Vaccines & Immunotherapeutics|October 31, 2017
Immunotherapy regimens for metastatic colorectal carcinomasBabar Bashir, Adam E Snook
Bioforum Europe : Trends and Techniques in Life Science Research|February 9, 2016
CANCER MUCOSA ANTIGENS A NOVEL PARADIGM IN CANCER IMMUNOTHERAPEUTICSAdam E Snook, Scott A Waldman
Discovery Medicine|November 27, 2014
Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancerMichael S Magee, Adam E Snook
Discovery Medicine|March 2, 2013
Advances in cancer immunotherapyAdam E Snook, Scott A Waldman
Personalized Medicine|May 17, 2018
The swinging pendulum of cancer immunotherapy personalizationTara S Abraham, Adam E Snook
Expert Review of Clinical Pharmacology|February 20, 2026
Could GUCY2C-targeted pharmacotherapy be effective in treating colorectal cancer?Scott A Waldman, Adam E Snook
Vaccines|November 27, 2021
Cancer Vaccines and Immunotherapy for Tumor Prevention and TreatmentJagmohan Singh, Wilbur B Bowne, Adam E Snook
Immunotherapy|June 13, 2022
Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB and PD-L1Daniel S Lefler, Adam E Snook, Babar Bashir
Pageof 10